C4 Therapeutics, Inc.
Patent Applications and Registrations
Patent applications and USPTO patent grants for C4 Therapeutics, Inc..The latest application filed is for "dihydrobenzimidazolones for medical treatment".
- C4 Therapeutics, Inc. - Watertown MA US
Trademarks
| Patent | Date |
|---|---|
| Dihydrobenzimidazolones For Medical Treatment App 20220289738 - Norcross; Roger ; et al. | 2022-09-15 |
| Degraders And Degrons For Targeted Protein Degradation App 20220251061 - Phillips; Andrew J. ; et al. | 2022-08-11 |
| Tricyclic degraders of Ikaros and Aiolos Grant 11,407,732 - Henderson , et al. August 9, 2 | 2022-08-09 |
| Dihydroquinolinones for medical treatment Grant 11,401,256 - Norcross , et al. August 2, 2 | 2022-08-02 |
| Compounds For Targeted Degradation Of Brd9 App 20220098194 - Nasveschuk; Christopher G. ; et al. | 2022-03-31 |
| Dihydrobenzimidazolones for medical treatment Grant 11,254,672 - Norcross , et al. February 22, 2 | 2022-02-22 |
| Spirocyclic degronimers for target protein degradation Grant 11,185,592 - Phillips , et al. November 30, 2 | 2021-11-30 |
| Compounds For The Degradation Of Brd9 Or Mth1 App 20210198256 - Nasveschuk; Christopher G. ; et al. | 2021-07-01 |
| Spirocyclic Degronimers For Target Protein Degradation App 20210106688 - Phillips; Andrew J. ; et al. | 2021-04-15 |
| Spirocyclic Compounds App 20210070763 - Nasveschuk; Christopher G. ; et al. | 2021-03-11 |
| Spirocyclic Compounds App 20210032245 - Nasveschuk; Christopher G. ; et al. | 2021-02-04 |
| Heterocyclic degronimers for target protein degradation Grant 10,905,768 - Phillips , et al. February 2, 2 | 2021-02-02 |
| Cereblon Binders For The Degradation Of Ikaros App 20210009559 - Henderson; James A. ; et al. | 2021-01-14 |
| C3-carbon linked glutarimide degronimers for target protein degradation Grant 10,849,982 - Phillips , et al. December 1, 2 | 2020-12-01 |
| Bifunctional Molecules That Degrade Egfr App 20200361930 - Duplessis; Martin ; et al. | 2020-11-19 |
| Bifunctional Inhibitors With Egfr Having A E3 Ubiquitin Ligase Moiety App 20200308171 - Jaeschke; Georg ; et al. | 2020-10-01 |
| Dihydrobenzimidazolones For Medical Treatment App 20200207764 - Norcross; Roger ; et al. | 2020-07-02 |
| Glutarimides For Medical Treatment App 20200207783 - Norcross; Roger ; et al. | 2020-07-02 |
| Dihydroquinolinones For Medical Treatment App 20200207733 - Norcross; Roger ; et al. | 2020-07-02 |
| Spirocyclic degronimers for target protein degradation Grant 10,660,968 - Phillips , et al. | 2020-05-26 |
| Heterocyclic degronimers for target protein degradation Grant 10,646,575 - Phillips , et al. | 2020-05-12 |
| N/o-linked Degrons And Degronimers For Protein Degradation App 20200140456 - Phillips; Andrew J. ; et al. | 2020-05-07 |
| C3-carbon Linked Glutarimide Degronimers For Target Protein Degradation App 20190076542 - Phillips; Andrew J. ; et al. | 2019-03-14 |
| Heterocyclic Degronimers For Target Protein Degradation App 20190076541 - Phillips; Andrew J. ; et al. | 2019-03-14 |
| Amine-linked C3-glutarimide Degronimers For Target Protein Degradation App 20190076539 - Phillips; Andrew J. ; et al. | 2019-03-14 |
| NCAGE Code | 7ZW60 | C4 THERAPEUTICS INC |
| CAGE Code | 7ZW60 | C4 THERAPEUTICS INC |
| SEC | 0001662579 | C4 Therapeutics, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 